Place of care and costs associated with acute episodes and remission in bipolar I disorder

被引:3
|
作者
McIntyre, Roger S. [1 ]
Higa, Sara [2 ]
Doan, Quan, V [3 ]
Amari, Diana [3 ]
Oliveri, David [3 ]
Gillard, Patrick [2 ]
Harrington, Amanda [2 ]
机构
[1] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[2] AbbVie, Irvine, CA USA
[3] Genesis Res, Hoboken, NJ USA
关键词
Bipolar I disorder; mania; depression; remission; inpatient costs; outpatient costs; claims database analysis; ECONOMIC BURDEN; UNITED-STATES; ADHERENCE; OUTCOMES;
D O I
10.1080/13696998.2022.2120264
中图分类号
F [经济];
学科分类号
02 ;
摘要
Aims To our knowledge, literature describing the place of care and associated costs during acute bipolar I disorder (BP-I) episodes is limited. We conducted a claims-based retrospective study to address this gap. Materials and methods Adults with BP-I were identified via IBM MarketScan Commercial and Medicare Supplemental databases. The acute episode index date was defined by >= 1 inpatient BP-I claim(s) or >= 1 outpatient or >= 3 outpatient BP-I claims (depending on visit type) in a 2-week (manic/mixed) or 4-week (depressive) period. Likely acute episodes were defined as 3- and 6-week periods for manic/mixed and depressive episodes, respectively; total mental health-related medical costs (health plan + patient) were collected during these intervals and stratified by setting (inpatient versus outpatient). Initial and subsequent episodes were captured; data were reported in subgroups without and with clozapine use, a proxy for disease severity. The remission index date was the earliest outpatient claim with a bipolar remission diagnosis with no acute episode or treatment. Remission costs were collected over a 3-month period. All results were analyzed descriptively. Results A total of 41,516 patients with 130,221 acute manic/mixed episodes and 47,763 patients with 149,207 acute depressive episodes met the study criteria. Over 84% of acute episodes were treated in outpatient settings. Mental health-related medical costs for manic/mixed episodes were $15,444 for inpatient and $1,577 for outpatient settings; inpatient and outpatient costs for depressive episodes were $17,376 and $2,154, respectively. Health plans covered approximately 78% of medical costs for both episode types with and without prior clozapine use. A total of 8,143 patients met remission criteria; the total 3-month outpatient costs were $1,225. Conclusions Most BP-I acute manic/mixed or depressive episodes were treated in the outpatient setting. Episodes with inpatient care were 8-10 times more costly than outpatient-only episodes. Health plans covered most medical costs, but additional patient-incurred out-of-pocket costs remained.
引用
收藏
页码:1110 / 1117
页数:8
相关论文
共 50 条
  • [1] Place of care and costs associated with acute episodes and remission in schizophrenia
    McIntyre, Roger S.
    Higa, Sara
    Doan, Quan, V
    Amari, Diana T.
    Mercer, Daniel
    Gillard, Patrick
    Harrington, Amanda
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (05): : 499 - 508
  • [2] Cytokine profiles in bipolar affective disorder during acute episodes and in remission
    Remlinger-Molenda, A.
    Wojciak, P.
    Kostrzewa, A.
    Karczewski, J.
    Wiktorowicz, K.
    Rybakowski, J. K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S415 - S416
  • [3] Frequency of hospitalisations and inpatient care costs of manic episodes - In patients with bipolar I disorder in France
    de Zelicourt, M
    Dardennes, R
    Verdoux, W
    Gandhi, G
    Khoshnood, B
    Chomette, E
    Papatheodorou, ML
    Edgell, ET
    Even, C
    Fagnani, F
    PHARMACOECONOMICS, 2003, 21 (15) : 1081 - 1090
  • [4] Efficacy and safety of iloperidone in acute manic and mixed episodes associated with bipolar I disorder
    Czeisler, Emily
    Torres, Rosarelis
    Smieszek, Sandra
    Xiao, Changfu
    Polyperopoulos, Christos
    Birznieks, Gunther
    Polyperopoulos, Mihael
    BIPOLAR DISORDERS, 2023, 25 : 56 - 56
  • [5] Patterns of improvement in patients with acute depressive episodes of bipolar I disorder and bipolar II disorder
    Datto, C.
    Mullen, J.
    Pottorf, W.
    LaPorte, S.
    Liss, C.
    BIPOLAR DISORDERS, 2015, 17 : 89 - 89
  • [6] Child bipolar I disorder is associated with manic episodes in adulthood
    Carlson, Gabrielle A.
    EVIDENCE-BASED MENTAL HEALTH, 2009, 12 (03) : 74 - 74
  • [7] EFFICACY AND SAFETY OF CARIPRAZINE IN PATIENTS WITH ACUTE MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER
    Calabrese, J. R.
    Sachs, G. S.
    Lu, K.
    Debelle, M.
    Laszlovszky, I.
    Durgam, S.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [8] Mitochondrial respiratory capacity in patients with acute episodes of bipolar disorder compared with clinical remission
    Gimenez-Palomo, A.
    Guitart-Mampel, M.
    Meseguer, A.
    Valenti, M.
    Bracco, L.
    Andreu, H.
    Vieta, E.
    Garrabou, G.
    Pacchiarotti, I.
    EUROPEAN PSYCHIATRY, 2024, 67 : S80 - S81
  • [9] Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder
    Warrington, Lewis
    Lombardo, Ilise
    Loebel, Antony
    Ice, Kathleen
    CNS DRUGS, 2007, 21 (10) : 835 - 849
  • [10] Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder
    Ketter, TerenceA.
    Yang, Ronghua
    Frye, Mark A.
    JOURNAL OF AFFECTIVE DISORDERS, 2015, 181 : 87 - 91